Pattern Bioscience is poised to redefine patient care in infectious diseases with its rapid diagnostic technology. By integrating single-cell analysis of microorganisms with advanced machine learning tools, this company significantly shortens the time to identify pathogens and determine antibiotic susceptibility, from days to mere hours. Such a pioneering approach not only enhances the efficiency of medical treatments but also supports healthcare systems in reducing costs and improving patient outcomes.